Optimizing first-line NALIRIFOX and exploring the role of the microbiota in second-line pancreatic cancer treatment: the PRODIGE 105-GERCOR 116 PANORAMIX trial

Digestive and Liver Disease · Elsevier

Аннотация

Publication date: December 2026 Source: Digestive and Liver Disease, Volume 58, Issue 12 Author(s): Matthieu Delaye, Marc Hilmi, Paul Gougis, Christelle d’ Engremont, Julie Lavole, Pauline Vaflard, Olivier Bouché, Jean-Baptiste Bachet, Nicolas Williet, Brice Chanez, Gaël Roth, Victoire de Lastours, Victoire Cardot-Ruffino, Marie-Line Garcia Larnicol, Dewi Vernerey, Cindy Neuzillet

Читать у издателя →

Похожие статьи